DXSP DXS International Plc

 
TIDMDXSP 
 
 
   DXS INTERNATIONAL PLC 
 
   (AQSE: DXSP) 
 
   Publication of Investor Presentation 
 
   DXS International plc ("DXSP" or the "Company"), the AQSE quoted 
clinical decision support developer and supplier of clinical decision 
support systems, is pleased to confirm that an updated corporate 
presentation is now available for download from the Corporate Documents 
section of the Company's website at 
https://www.globenewswire.com/Tracker?data=gr0xodcE--LH_IHFn3s2-Dcy6r72eDNb8HcjH_F77GZx6SfH67i7uxf08zk4xWLNexnCANF9__WpOJOBjIjy0G2JzBq2uqZ9xqsuAu4KmI90eq90uOuMvM69enbb9rcAYbfOgQNIB5DolDhDJh2mqIRIoY4F6c9xVcUpiegqd_6AocRmTRU5eRqbHaqbYfTx 
https://www.dxs-systems.co.uk/corporate-documents.php 
 
   Contacts: 
 
 
 
 
David Immelman (Chief Executive)               01252 719800 
 DXS International plc                david@dxs-systems.com 
 
 https://www.dxs-systems.co.uk 
 
 
 
 
 
 
Corporate Advisor 
City & Merchant 
 David Papworth     020 7101 7676 
 
 
 
 
 
 
Corporate Broker 
Hybridan LLP 
 Claire Louise Noyce   020 3764 2341 
 
 
   Notes to Editors 
 
   About DXS: 
 
   DXS International presents up to date treatment guidelines and 
recommendations, from Clinical Commissioning Groups and other trusted 
NHS sources, to doctors, nurses and pharmacists in their workflow and 
during the patient consultation. This effective clinical decision 
support ultimately translates to improved healthcare outcomes delivered 
more cost effectively and which should significantly contribute towards 
the NHS achieving its projected efficiency savings. 
 
 
 
 

(END) Dow Jones Newswires

March 09, 2021 02:00 ET (07:00 GMT)

DXS (AQSE:DXSP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

DXS (AQSE:DXSP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024